Table 1.

Patients characteristics, type of cancer and tumor, and normal tissue analyzed

Study/patientAge (y)GenderPrimary site of diseaseLesions evaluated (no. of lesions)Size of lesions (cm)*Normal tissue evaluated
CA4P/146FColorectalLiver met. (1), Lung met. (1)a = 4 b = 2K, S
CA4P/227FOsteosarcomaLiver met. (2), Lung met. (2)a = 4 b = 4 c = 2 d = 2K, S
CA4P/344FColorectalLiver met. (1)a = 5K, S
CA4P/424MHepatomaPrimary (1)a = 10K, S
CA4P/564MGISTLiver met. (3)a = 8 b = 6 c = 4K, S
CA4P/647MOsophagealPara-aortic nodes (1)a = 4K, S
CA4P/752MRenal cellPrimary (1)a = 15K
CA4P/859FHepatomaPrimary (2)a = 5 b = 5K, S
CA4P/964MColorectalLiver met. (1)a = 11K, S
N/C/158FColorectalLiver met. (4)a = 3 b = 3 c = 3 d = 2K, S, L
N/C/274MColorectalLiver met. (2)a = 4 b = 2K, S, L
N/C/374MColorectalLiver met. (2)a = 10 b = 2K, S, L
N/C/447FColorectalLiver met. (2)a = 6 b = 4K, S, L
N/C/551MColorectalLiver met. (3)a = 6 b = 3 c = 3K, S, L
N/C/677FColorectalLymph nodes (2)a = 1.5, b = 1.5K, S, L
IFN/167MColorectalLiver met. (2)a = 3 b = 3S, L
IFN/246FColorectalLiver met. (3)a = 7 b = 5 c = 3K, S, L
IFN/361MGastricLiver met. (1)a = 3.5K, S, L
IFN/454FColorectalLiver met. (2)a = 10 b = 7S, L
IFN/580FColorectalLiver met. (1)a = 5K, S, L
IFN/659MColorectalLiver met. (2)a = 5 b = 6S, L
  • Abbreviations: F, female; M, male; Liver met, liver metastasis; K, kidney; S, spleen; L, liver.

  • * a, b, c, and d refers to individual lesions analyzed.

  • Patient scanned before intervention only.

  • Only liver metastases evaluated in the analysis of the effect of N/C.